Mirum Pharmaceuticals Inc (MIRM) is a biotechnology company listed on NASDAQ.
Latest reported MIRM revenue for 2026-06-30 was $336.1M. Net income was -$857.4M. MIRM currently screens at market cap $6.22B.
Use this MIRM page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the MIRM quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the MIRM SEC filings page. Lician reads the product cache first so this HTML stays unique to Mirum Pharmaceuticals Inc even when a live quote feed is slow.
Latest cached year on this hub. Full MIRM income, balance, and cash tables.